This study investigates advanced solid tumours. The purpose of this study is to evaluate an investigational medication.
The study evaluates the safety and effectiveness of the investigational medication.
- Who can participate: Adults aged 18 and over with advanced solid tumours that have not responded to conventional treatment may participate. Participants must meet specific health criteria.
- Study details: Participants will take the investigational medication alone or with another treatment. Some participants may receive a placebo.